Frequency, clinical pattern and outcome of thrombosis in cancer patients in Saudi Arabia

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1311-1315

  Aleem, Aamer ^a   Abdul Rahman, Al Diab ^a   Alsaleh, Khalid ^a   Algahtani, Farjah ^a   Alsaeed, Eyad ^a   Iqba, Zafar ^b   Sherif El Sherkawy, Mohamed ^b  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer; Deep venous thrombosis; Pulmonary embolism; Saudi Arabia.; VTE

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; FEMALE; HUMAN; LUNG EMBOLISM; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY; SAUDI ARABIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SAUDI ARABIA; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN; YOUNG ADULT;

EID: 84873028005     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1311     Document Type: Article

References (42)

1. Abba AA, Al Ghonaim MA, Rufai AM (2004). Physicians' practice for prevention of venous thromboembolism in medical patients. J Coll Physicians Surg Pak, 14, 211-4.
2. Agnelli G, George DJ, Kakkar AK, et al (2012). SAVE-ONCO Investigators (2012). Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med, 366, 601-9.
3. Al Diab AI (2010). Cancer-related venous thromboembolism: insight into underestimated risk facrors. Hematol Oncol Stem Cell Ther, 3, 191-5.
4. Amin A, Stemkowski S, Lin J, Yang G (2008). Appropriate thromboprophylaxis in hospitalized cancer patients. Clin Adv Hematol Oncol, 6, 910-20.
5. Beck-Razi N, Kuzmin A, Koren D, (2010). Asymptomatic deep vein thrombosis in advanced cancer patients: the value of venous sonography. J Clin Ultrasound, 38, 232-7.
6. Chew HK, Davies AM, Wun T, et al (2008). The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost, 6, 601-8.
7. Chew HK, Wun T, Harvey D, Zhou H, White RH (2006). Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med, 166, 458-64.
8. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM (2007). Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Am J Roentgenol, 189, 162-70.
9. Elting LS, Escalante CP, Cooksley C, et al (2004). Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med, 164, 1653-61.
10. Engelke C, Rummeny EJ, Marten K (2006). Pulmonary embolism at multi-detector row CT of chest: 1-year survival of treated and untreated patients. Radiology, 239, 563-75.
11. Gladish GW, Choe DH, Marom EM, et al (2006). Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology, 240, 246-55.
12. Goldhaber SZ, Tapson VF (2004). DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol, 93, 259-62.
13. Gomes MP, Deitcher SR (2003). Diagnosis of venous thromboembolic disease in cancer patients. Oncology (Williston Park, NY), 17:126-35, 139; discussion 139-44.
14. Gross CP, Galusha DH, Krumholz HM (2007). The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med, 22, 321-6.
15. Heidrich H, Konau E, Hesse P (2009). Asymptomatic venous thrombosis in cancer patients-a problem often overlooked. Results of a retrospective and prospective study. Vasa, 38, 160-6.
16. Imberti D, Agnelli G, Ageno W, et al (2008). MASTER Investigators. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. Haematologica, 93, 273-8.
17. Keenan CR, White RH (2007). The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med, 13, 377-83.
18. Khorana AA, Streiff MB, Farge D (2009). Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol, 27, 4919-26.
19. Khorana AA, Connolly GC (2009). Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol, 27, 4839-47.
20. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008). Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, 111, 4902-7.
21. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost, 5, 632-4.
22. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007). Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer, 110, 2339-46.
23. Klatsky AL, Armstrong MA, Poggi J (2000). Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol, 85, 1334-7.
24. Kröger K, Weiland D, Ose C, et al (2006). Risk factors for venous thromboembolic events in cancer patients. Ann Oncol, 17, 297-303.
25. Monreal M, Falgá C, Valdés M, et al (2006). Riete Investigators. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry. J Thromb Haemost, 4, 1950-6.
26. O'Connell CL, Ghalichi M, Boyle S (2008). Unsuspected pulmonary emboli identified on routine cancer staging MDCT scans: Impact on cancer survival. Blood, 112, 3818.
27. O'Connell CL, Boswell WD, Duddalwar V, et al (2006). Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol, 24, 4928-32.
28. Ogren M, Bergqvist D, Wahlander K, Eriksson H, Sternby NH (2006). Trousseau's syndrome - what is the evidence? A population-based autopsy study. Thromb Haemost, 95, 541-5.
29. Otten HM, Mathijssen J, Ten Cate H, et al (2004). Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med, 164, 190-4.
30. Ottinger H, Belka C, Kozole G, et al (1995). Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: Incidence, causes and prognostic relevance. Eur J Haematol, 54, 186-94.
31. Prandoni P, Lensing AW, Piccioli A, et al (2002). Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 3484-8.
32. Rashid ST, Thursz MR, Razvi NA, et al (2005). Venous thromboprophylaxis in UK medical inpatients. J R Soc Med, 98, 507-12.
33. Rita Larici R, Calandriello L, Maggi F (2007). Prevalence of incidental pulmonary emboli in oncology patients. Radiology, 245, 921-2.
34. Sallah S, Wan JY, Nguyen NP (2002). Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost, 87, 575-9.
35. Seddighzadeh A, Shetty R, Goldhaber SZ (2007). Venous thromboembolism in patients with active cancer. Thromb Haemost, 98, 656-61.
36. Silverstein MD, Heit JA, Mohr DN, et al (1998). Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med, 158, 585-93.
37. Sleiman Zade Asfahani WH, Taher AT, Al Rahawi D, Khalil I (2005). Venous thromboembolism in cancer patients referred to the American University of Beirut-Medical Center secondary to deep vein thrombosis; occurrence and risk factors. J Thromb Thrombolysis, 20, 179-82.
38. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000). Prognosis of cancers associated with venous thromboembolism. N Engl J Med, 343, 1846-50.
39. Vemulapalli S, Chintala L, Tsimberidou AM, et al (2009). Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience. Am J Hematol, 84, 408-13.
40. White RH, Zhou H, Romano PS (1998). Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med, 128, 737-40.
41. Woller SC, Stevens SM, Jones JP, et al (2011). Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med, 124, 947-54.
42. Wun T, White RH (2009). Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest, 27, 63-74.